Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study

被引:31
作者
Love, T. J. [1 ,2 ]
Gudjonsson, J. E. [3 ]
Valdimarsson, H. [4 ,5 ]
Gudbjornsson, B. [2 ,5 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Landspitali Univ Hosp, Ctr Rheumatol Res, Reykjavik, Iceland
[3] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA
[4] Landspitali Univ Hosp, Dept Immunol, Reykjavik, Iceland
[5] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland
关键词
DISTAL INTERPHALANGEAL JOINT; NAIL; THERAPY; DISEASE;
D O I
10.3109/03009741003604559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Psoriasis and psoriatic arthritis (PsA) are associated with nail changes. Recent reports suggest that nail changes may be a part of the enthesitis of PsA and that they predict the onset of arthritis among patients with psoriasis, but they have not reported on subclasses of nail changes. However, earlier reports suggested that onycholysis is the nail change most strongly associated with PsA. If nail changes in PsA are a sign of enthesitis, they might be associated with small joint disease in general and the objective of this study was to test this hypothesis. Methods: A total of 154 patients recruited through the Reykjavik Psoriatic Arthritis Study had a joint, skin, and nail evaluation. Associations with small joint disease were tested using univariate analysis, and confirmed in a multivariate model. Results: Onycholysis had a strong association with small joint involvement [odds ratio (OR) 3.42, 95% confidence interval (CI) 1.41-8.92], while other types of nail changes did not. The number of swollen joints and shorter disease duration were also associated with small joint disease. Conclusions: Onycholysis is associated with small joint disease in PsA. Future studies of PsA should report the subtypes of nail changes. Longitudinal studies are needed to determine whether onycholysis predicts PsA.
引用
收藏
页码:299 / 302
页数:4
相关论文
共 18 条
[1]  
ALONSO JCT, 1991, BRIT J RHEUMATOL, V30, P245
[2]   Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients [J].
deJong, EMGJ ;
Seegers, BAMPA ;
Gulinck, MK ;
Boezeman, JBM ;
vandeKerkhof, PCM .
DERMATOLOGY, 1996, 193 (04) :300-303
[3]   NAIL DYSTROPHY OF PSORIATIC-ARTHRITIS [J].
EASTMOND, CJ ;
WRIGHT, V .
ANNALS OF THE RHEUMATIC DISEASES, 1979, 38 (03) :226-228
[4]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[5]  
GLADMAN DD, 1987, Q J MED, V62, P127
[6]   Assessment of patients with psoriatic arthritis - A review of currently available measures [J].
Gladman, DD ;
Helliwell, P ;
Mease, PJ ;
Nash, P ;
Ritchlin, C ;
Taylor, W .
ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :24-35
[7]   Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial [J].
Gottlieb, Alice ;
Menter, Alan ;
Mendelsohn, Alan ;
Shen, Yaung-Kaung ;
Li, Shu ;
Guzzo, Cynthia ;
Fretzin, Scott ;
Kunynetz, Rod ;
Kavanaugh, Arthur .
LANCET, 2009, 373 (9664) :633-640
[8]   Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy [J].
Jiaravuthisan, Michael M. ;
Sasseville, Denis ;
Vender, Ronald B. ;
Murphy, Francis ;
Muhn, Channy Y. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (01) :1-27
[9]  
LAVARONI G, 1994, ACTA DERM-VENEREOL, V74, P113
[10]  
Love TJ, 2007, J RHEUMATOL, V34, P2082